KeraVision managers quit to save funds:
This article was originally published in Clinica
Executive Summary
KeraVision's chairman and CEO Thomas Loarie and president and chief operating officer John Galantic have both resigned in order to conserve cash at the Freemont, California-based company. KeraVision has FDA approval for its INTAC inserts for myopia.